This company has been marked as potentially delisted and may not be actively trading. Orchard Therapeutics (ORTX) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Orchard Therapeutics Short Interest DataOrchard Therapeutics (ORTX) has a short interest of 31,500 shares, representing 0.14% of the float (the number of shares available for trading by the public). This marks a 15.81% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 157,287 shares to cover all short positions.Current Short Interest31,500 sharesPrevious Short Interest27,200 sharesChange Vs. Previous Month+15.81%Dollar Volume Sold Short$517,860.00Short Interest Ratio0.3 Days to CoverLast Record DateJanuary 15, 2024Outstanding Shares22,760,000 sharesFloat Size22,370,000 sharesShort Percent of Float0.14%Today's Trading Volume0 sharesAverage Trading Volume157,287 sharesToday's Volume Vs. Average0% Short Selling Orchard Therapeutics? Sign up to receive the latest short interest report for Orchard Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartORTX Short Interest Over TimeORTX Days to Cover Over TimeORTX Percentage of Float Shorted Over Time Orchard Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/202431,500 shares $517,860.00 +15.8%0.1%0.3 $16.44 12/31/202327,200 shares $447,440.00 -33.7%0.1%0.2 $16.45 12/15/202341,000 shares $672,810.00 +1.2%0.2%0.2 $16.41 11/30/202340,500 shares $656,505.00 -6.9%0.2%0.2 $16.21 11/15/202343,500 shares $696,435.00 +57.6%0.2%0.2 $16.01 10/31/202327,600 shares $439,116.00 -62.8%0.2%0.1 $15.91 10/15/202374,100 shares $1.18 million +67.7%0.4%0.3 $15.98 9/30/202344,200 shares $341,666.00 +116.7%0.2%0.2 $7.73 9/15/202320,400 shares $105,162.00 +126.7%0.1%0.5 $5.16 8/31/20239,000 shares $44,550.00 +20.0%0.1%0.4 $4.95 Get the Latest News and Ratings for ORTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orchard Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/15/20237,500 shares $39,525.00 -14.8%0.0%0.3 $5.27 7/31/20238,800 shares $44,264.00 -59.8%0.1%0.2 $5.03 7/15/202321,900 shares $113,223.00 -74.6%0.1%0.5 $5.17 6/30/202386,200 shares $449,102.00 -14.0%0.5%1.9 $5.21 6/15/2023100,200 shares $496,992.00 +13.2%0.6%1.9 $4.96 5/31/202388,500 shares $424,800.00 +9.8%0.5%1.4 $4.80 5/15/202380,600 shares $433,628.00 -25.4%0.5%1.1 $5.38 4/30/2023108,100 shares $519,961.00 -1.2%0.6%1.7 $4.81 4/15/2023109,400 shares $548,641.00 -15.4%0.6%1.8 $5.02 3/31/2023129,300 shares $694,341.00 +46.9%0.8%2 $5.37 3/15/202388,000 shares $457,600.00 -91.9%0.7%0.8 $5.20 2/28/20231,080,000 shares $4.97 million +42.6%1.1%1 $4.60 2/15/2023757,600 shares $406,755.44 -4.8%0.7%0.8 $0.54 1/31/2023795,900 shares $442,997.94 +19.6%0.8%0.9 $0.56 1/15/2023665,500 shares $404,890.20 +38.5%0.6%0.8 $0.61 12/30/2022480,500 shares $178,265.50 -13.7%0.5%0.6 $0.37 12/15/2022556,800 shares $244,992.00 +67.5%0.5%1.7 $0.44 11/30/2022332,400 shares $147,020.52 +18.5%0.3%1.1 $0.44 11/15/2022280,600 shares $126,270.00 -9.8%0.2%0.9 $0.45 10/31/2022310,900 shares $140,588.98 +4.5%0.3%0.9 $0.45 10/15/2022297,400 shares $136,060.50 +9.5%0.3%0.6 $0.46 9/30/2022271,700 shares $135,850.00 -20.1%0.2%0.5 $0.50 9/15/2022340,200 shares $167,378.40 +17.4%0.3%0.5 $0.49 8/31/2022289,800 shares $150,753.96 +10.7%0.3%0.4 $0.52 8/15/2022261,800 shares $157,891.58 -63.9%0.2%0.3 $0.60 7/31/2022724,500 shares $383,985.00 -24.3%0.6%0.8 $0.53 7/15/2022957,500 shares $571,627.50 -29.6%0.8%1.1 $0.60 6/30/20221,360,000 shares $794,240.00 +2.3%1.2%1.7 $0.58 6/15/20221,330,000 shares $690,802.00 +61.5%1.1%1.9 $0.52 5/31/2022823,500 shares $374,692.50 +10.4%0.7%1.5 $0.46Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. 5/15/2022745,700 shares $353,461.80 -4.1%0.6%1.3 $0.47 4/30/2022777,900 shares $439,513.50 -48.8%0.7%1.3 $0.57 4/15/20221,520,000 shares $1.06 million -1.3%1.3%2.7 $0.69 3/31/20221,540,000 shares $1.10 million -7.8%1.3%2.5 $0.71 3/15/20221,670,000 shares $1.19 million +3.7%1.4%1.9 $0.71 2/28/20221,610,000 shares $1.43 million -6.9%1.4%1.8 $0.89 2/15/20221,730,000 shares $1.90 million +34.1%1.5%2 $1.10 1/31/20221,290,000 shares $1.32 million -8.5%1.1%1.3 $1.02 1/15/20221,410,000 shares $1.75 million -28.8%1.2%1.4 $1.24 12/31/20211,980,000 shares $2.61 million +15.8%1.7%1.9 $1.32 12/15/20211,710,000 shares $2.19 million -8.1%1.5%1.7 $1.28 11/30/20211,860,000 shares $2.51 million -67.0%1.6%1.9 $1.35 11/15/20215,640,000 shares $9.98 million -5.2%4.9%5.6 $1.77 10/29/20215,950,000 shares $11.42 million +2.6%5.2%6.4 $1.92 10/15/20215,800,000 shares $12.64 million +36.5%5.2%6.2 $2.18 9/30/20214,250,000 shares $9.78 million +8.4%3.8%4.8 $2.30 9/15/20213,920,000 shares $11.37 million -3.0%3.5%5.6 $2.90 8/31/20214,040,000 shares $11.15 million -7.8%3.6%6.3 $2.76 8/13/20214,380,000 shares $12.22 million +7.6%4.0%7.7 $2.79 7/30/20214,070,000 shares $11.68 million +11.8%3.7%7.2 $2.87 7/15/20213,640,000 shares $12.45 million -29.2%3.2%7.3 $3.42 6/30/20215,140,000 shares $22.56 million +6.4%4.5%10.4 $4.39 6/15/20214,830,000 shares $23.43 million +4.6%4.3%10.6 $4.85 5/28/20214,620,000 shares $24.16 million -2.5%4.1%9.5 $5.23 5/14/20214,740,000 shares $23.70 million +1.5%N/A7.1 $5.00 4/30/20214,670,000 shares $28.58 million -0.9%N/A3.9 $6.12 4/15/20214,710,000 shares $30.43 million -1.1%N/A3.3 $6.46 3/31/20214,760,000 shares $34.03 million -10.2%N/A2.6 $7.15 3/15/20215,300,000 shares $42.98 million +1.0%N/A2.3 $8.11 2/26/20215,250,000 shares $36.44 million +27.4%N/A2.3 $6.94 2/12/20214,120,000 shares $33.83 million +30.8%N/A1.9 $8.21 1/29/20213,150,000 shares $17.96 million +9.0%3.8%1.6 $5.70 1/15/20212,890,000 shares $20.26 million +36.3%3.4%1.9 $7.01 12/31/20202,120,000 shares $9.41 million -25.4%2.5%1.5 $4.44 12/15/20202,840,000 shares $12.92 million -2.4%3.4%3.9 $4.55 11/30/20202,910,000 shares $14.23 million -10.7%3.5%4.6 $4.89 11/15/20203,260,000 shares $15.32 million +4.8%3.9%3.2 $4.70 10/30/20203,110,000 shares $13.22 million -1.0%3.7%3 $4.25 10/15/20203,140,000 shares $13.41 million -4.3%3.7%3 $4.27 9/30/20203,280,000 shares $13.48 million +18.4%3.9%3.3 $4.11 9/15/20202,770,000 shares $14.74 million +3.8%3.3%2.8 $5.32 8/31/20202,670,000 shares $15.83 million +35.5%3.2%2.7 $5.93 8/14/20201,970,000 shares $9.38 million -1.5%2.4%2.5 $4.76 7/31/20202,000,000 shares $10.28 million +2.0%2.4%4.2 $5.14 7/15/20201,960,000 shares $11.07 million -8.4%2.4%4.5 $5.65 6/30/20202,140,000 shares $12.84 million +22.3%2.6%5.2 $6.00 6/15/20201,750,000 shares $13.39 million +47.1%2.1%5.3 $7.65 5/29/20201,190,000 shares $11.31 million +0.9%1.4%3.7 $9.50 5/15/20201,180,000 shares $11.21 million +51.5%1.4%3.1 $9.50 ORTX Short Interest - Frequently Asked Questions What is Orchard Therapeutics' current short interest? Short interest is the volume of Orchard Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 31,500 shares of ORTX short. 0.14% of Orchard Therapeutics' shares are currently sold short. Learn More on Orchard Therapeutics' current short interest. What is a good short interest percentage for Orchard Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.14% of Orchard Therapeutics' floating shares are currently sold short. Is Orchard Therapeutics' short interest increasing or decreasing? Orchard Therapeutics saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 31,500 shares, an increase of 15.8% from the previous total of 27,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Orchard Therapeutics' float size? Orchard Therapeutics currently has issued a total of 22,760,000 shares. Some of Orchard Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Orchard Therapeutics currently has a public float of 22,370,000 shares. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.10 billion), General Motors ($3.90 billion), Charter Communications, Inc. ($3.31 billion), Occidental Petroleum Co. ($2.91 billion), Tractor Supply ($2.75 billion), Moderna, Inc. ($2.44 billion), Coinbase Global, Inc. ($2.10 billion), United Rentals, Inc. ($2.09 billion), Royal Caribbean Cruises Ltd. ($2.03 billion), and Rivian Automotive, Inc. ($1.89 billion). View all of the most shorted stocks. What does it mean to sell short Orchard Therapeutics stock? Short selling ORTX is an investing strategy that aims to generate trading profit from Orchard Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Orchard Therapeutics? A short squeeze for Orchard Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ORTX, which in turn drives the price of the stock up even further. How often is Orchard Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ORTX, twice per month. The most recent reporting period available is January, 15 2024. More Short Interest Resources from MarketBeat Related Companies Apollomics Short Squeeze BriaCell Therapeutics Short Squeeze Cardio Diagnostics Short Squeeze CERo Therapeutics Short Squeeze Clene Short Squeeze Conduit Pharmaceuticals Short Squeeze enGene Short Squeeze Fortress Biotech Short Squeeze Immatics Short Squeeze Jasper Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ORTX) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchard Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchard Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ORTX Stock Free ORTX Stock Alerts